Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BVSDXCM

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BVS

62/100

DXCM

70/100

Quality

Is it a profitable, well-run business?

BVS

5.6/10

DXCM

8.1/10

Growth

Is the company growing?

BVS

4.8/10

DXCM

6.4/10

Valuation

Is the price reasonable? (higher = cheaper)

BVS

7.5/10

DXCM

5.8/10

Risk

How risky are the shares? (higher = lower risk)

BVS

5.4/10

DXCM

6.1/10

Momentum

Is the share price trending up?

BVS

8.3/10

DXCM

8.2/10

Financial strength

Is the balance sheet healthy?

BVS

4.3/10

DXCM

8.6/10

The balanced view

Model-generated

Bioventus Inc.

This company scores above average, with a positive price trend and a reasonable valuation, although its balance sheet looks stretched.

Leads on: valuation, momentum

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: balance sheet is stretched (Interest coverage: 3.1x)

DexCom, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, growth, risk, financial strength

Best feature: healthy balance sheet (Piotroski F-Score: 8/9)

Watch out: weakest area: valuation (DCF upside: -52.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.